BMJ Publishing Group, Journal of Neurology, Neurosurgery and Psychiatry, 12(86), p. 1291-1298, 2015
Full text: Download
To evaluate candidate outcomes for disease-modifying trials in Huntington's disease (HD) over 6-month, 9-month and 15-month intervals, across multiple domains. To present guidelines on rapid efficacy readouts for disease-modifying trials.